Allogeneic Marrow Stem-Cell Transplantation From Human Leukocyte Antigen–Identical Siblings Versus Human Leukocyte Antigen–Allelic–Matched Unrelated Donors (10/10) in Patients With Standard-Risk ...
The U.S. Food and Drug Administration late Tuesday approved a new way for people to screen for signs of cervical cancer. Patients using the new method will self-screen with a swab at the doctors ...
Study from New Zealand was of particular benefit to Mori and under-screened women ...
Anlotinib plus sintilimab in patients with recurrent advanced cervical cancer: A prospective, multicenter, single-arm, phase II clinical trial. This is an ASCO Meeting Abstract from the 2021 ASCO ...
The FDA has approved Roche's new test for human papillomavirus (HPV), the first one-pass test to specifically identify the two HPV strains that cause 70% of cervical cancers. The sexually transmitted ...
It may be a little too soon to officially say goodbye to the pap smear (or good riddance), but we may be getting closer to a time when it is no longer the frequent and unpleasant experience that it is ...
A test for human papillomavirus infection is better than the standard Pap smear at catching cervical cancer early, researchers report. The study of women age 30 and over makes the case for changing ...
The adjusted incidence of cervical carcinoma among Israeli Jewish women is ∼5 out of 100 000. This retrospective study sought to determine the clinical implications of finding atypical glandular cells ...